Clinical Trial Update: Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of clevudine plus lamivudine in lamivudine-resistant chronic hepatitis B was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Clevudine (clevudine)
• Lamivudine (lamivudine)

Snippet

Sponsor: Inje University | Conditions: Chronic Hepatitis B | Phase 4 | Status: TERMINATED